Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Specificaties
Gebonden, 362 blz. | Engels
Springer Berlin Heidelberg | 2008e druk, 2007
ISBN13: 9783540736769
Rubricering
Juridisch :
Springer Berlin Heidelberg 2008e druk, 2007 9783540736769
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.

Specificaties

ISBN13:9783540736769
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:362
Uitgever:Springer Berlin Heidelberg
Druk:2008

Inhoudsopgave

Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications.- Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders.- Multiple Sclerosis Genetics.- Imaging of Remyelination and Neuronal Health.- Immunological Aspects of Axon Injury in Multiple Sclerosis.- The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease.- Genetic Analysis of CNS Remyelination.- Remyelination in Experimental Models of Toxin-Induced Demyelination.- Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease.- Neuroimaging of Demyelination and Remyelination Models.- Hormonal Influences in Multiple Sclerosis.- Statins and Demyelination.- Role of Uric Acid in Multiple Sclerosis.- Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker.

Net verschenen

Rubrieken

Populaire producten

    Personen

      Trefwoorden

        Advances in Multiple Sclerosis and Experimental Demyelinating Diseases